Skip to content

Clinical trials

Phase 1 Cardiomyopathy, Dilated trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiomyopathy, Dilated Phase: Phase 1 Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20121
20141
20172
20211
20231
20241
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting4
Unknown status4
Completed2
Terminated2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Capricor Inc.1
Emory University1
Francis D. Pagani1
HELP Therapeutics Co., Ltd.1
Hospital Universitario Dr. Jose E. Gonzalez1
Instituto de Molestias Cardiovasculares1
MyoKardia, Inc.1
Okayama University1
Rocket Pharmaceuticals Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiomyopathy, Dilated13
Heart Failure8
Cardiovascular Diseases3
Cardiomyopathies2
Heart Diseases2
Dilatation, Pathologic1
Pathologic Processes1
Ventricular Dysfunction1

Trials

Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.